An important aspect of developing treatments against cancer consists in correcting the defects caused by the abnormal activity of oncogenes and tumor suppressor genes. This usually includes the assignment of cancer- related gene products to their respective biochemical pathways. It has been shown that the genetics available in model organisms such as yeast, nematodes, flies, and mice can be highly advantageous for these projects. Despite the power of model organisms, the number of genes with a function assigned is relatively small and thus the functional analysis of cancer-related orthologs is still relatively tedious. However, with the complete sequence of the genome of most model organisms anticipated to be available soon, several laboratories have initiated the development of genome-wide gene-function analysis projects. Such projects, collectively referred to as """"""""functional genomics"""""""" include genome-wide expression analysis, gene knock-outs and protein-protein interaction mapping. They are expected to reveal gene functions at a drastically increased rate. In this context, the long-term goal of our laboratory is to generate a comprehensive protein-protein interaction map for the nematode C. elegans. This will be achieved in three steps: Step I: validation of our improved version of the yeast two-hybrid system to generate protein interaction maps (funded by an R01 grant from the NHRGI); Step II: development of new high-throughput technologies for protein interaction mapping (object of this grant); step III: production phase (planned for the long-term and not the object of this grant). In step II, we plan to automate most steps of the two-hybrid methodology using a new cloning method, referred to as Gateway cloning. Gateway allows the transfer of DNA inserts between donor plasmids (or PCR products) and recipient plasmids. It is based on an in vitro site- specific recombination event mediated by purified phage lambda proteins and thus eliminates the need for restriction enzymes and ligases. It is fast and reversible, and the whole procedure can take place in 96- well plates, which means that automation is possible. In summary, Gateway will allow us to go in and come out of the two-hybrid in a completely automated series of steps. We will first develop the Gateway technology in the context of the two- hybrid system (R21). Then we will develop high-throughput methods for protein interaction mapping based on the use of the Gateway/two-hybrid system (R33). We will also adapt the technology so that other worm functional projects can benefit from it.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants Phase II (R33)
Project #
5R33CA081658-04
Application #
6513582
Study Section
Special Emphasis Panel (ZCA1-SRRB-C (J2))
Program Officer
Gallahan, Daniel L
Project Start
1999-05-01
Project End
2003-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
4
Fiscal Year
2002
Total Cost
$539,852
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Charloteaux, Benoit; Zhong, Quan; Dreze, Matija et al. (2011) Protein-protein interactions and networks: forward and reverse edgetics. Methods Mol Biol 759:197-213
Wang, Jinling; Robida-Stubbs, Stacey; Tullet, Jennifer M A et al. (2010) RNAi screening implicates a SKN-1-dependent transcriptional response in stress resistance and longevity deriving from translation inhibition. PLoS Genet 6:
Dreze, Matija; Charloteaux, Benoit; Milstein, Stuart et al. (2009) 'Edgetic' perturbation of a C. elegans BCL2 ortholog. Nat Methods 6:843-9
Boxem, Mike; Maliga, Zoltan; Klitgord, Niels et al. (2008) A protein domain-based interactome network for C. elegans early embryogenesis. Cell 134:534-45
Rual, Jean-Francois; Klitgord, Niels; Achaz, Guillaume (2007) Novel insights into RNAi off-target effects using C. elegans paralogs. BMC Genomics 8:106
Fernandez, Anita G; Gunsalus, Kristin C; Huang, Jerry et al. (2005) New genes with roles in the C. elegans embryo revealed using RNAi of ovary-enriched ORFeome clones. Genome Res 15:250-9
Wei, Chaochun; Lamesch, Philippe; Arumugam, Manimozhiyan et al. (2005) Closing in on the C. elegans ORFeome by cloning TWINSCAN predictions. Genome Res 15:577-82
Rual, Jean-Francois; Ceron, Julian; Koreth, John et al. (2004) Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 14:2162-8
Lamesch, Philippe; Milstein, Stuart; Hao, Tong et al. (2004) C. elegans ORFeome version 3.1: increasing the coverage of ORFeome resources with improved gene predictions. Genome Res 14:2064-9
Boulton, Simon J; Martin, Julie S; Polanowska, Jolanta et al. (2004) BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans. Curr Biol 14:33-9

Showing the most recent 10 out of 18 publications